ORIC Pharmaceuticals, Inc. (ORIC) Misses Q1 EPS by 2c
Tweet
Share
E-mailGet Alerts ORIC Hot Sheet
Join SI Premium – FREE
ORIC Pharmaceuticals, Inc. (NASDAQ: ORIC) reported Q1 EPS of ($0.34), $0.02 worse than the analyst estimate of ($0.32).
For earnings history and earnings-related data on ORIC Pharmaceuticals, Inc. (ORIC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- VNET Group (VNET) Misses Q2 EPS by 164c
- H.C. Wainwright Reiterates Buy Rating on Invivyd Inc. (IVVD)
- iQIYI (IQ) Misses Q2 EPS by 21c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
